N2OFF enters €6M credit facility, pursues spin-off and drug discovery acquisition

Nexentis Technologies Inc.

€6M non-recourse credit facility at 7% interest; warrant for 1.85M shares at $1.00 exercise price.
Board approved potential spin-off of cleantech units NTWO OFF and Save Foods into separate public company; N2OFF to retain ≥75% in Save Foods.
Non-binding LOI to acquire a computationally advanced drug discovery company at valuation of at least $5M (possible $2M increase).
Acquisition consideration would be cash and equity; company intends to tap new pharmaceutical market.

item 2.03 item 1.01 item 3.02 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.